Fluphenazine Decanoate recalls
The FDA has published 2 recalls involving Fluphenazine Decanoate since 2017. The latest was reported on 11 Dec 2019. Most were for potency & assay. AuroMedics Pharma has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 11 Dec 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why fluphenazine decanoate is recalled
Companies
By year
All fluphenazine decanoate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fluphenazine Decanoate Injection USP 125mg/ Multiple Dose Vial) recalled | AuroMedics Pharma | Other | Nationwide |
| Drug | CLASS III | Fluphenazine Decanoate Injection recalled by Fresenius Kabi USA | Fresenius Kabi USA | Potency & Assay | Nationwide |
Should you stop taking Fluphenazine Decanoate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.